Plasma miR ‐1247‐5p, miR ‐301b‐3p and miR ‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancer-Reference-Cited by-同舟云学术

Plasma miR ‐1247‐5p, miR ‐301b‐3p and miR ‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancer

Published:2020-12-28 Issue:4 Volume:12 Page:539-548
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Dong Xiaohan¹²,Chang Minghui¹²,Song Xingguo¹³,Ding Shanshan¹,Xie Li¹,Song Xianrang¹³^ORCID

Affiliation:

1. Department of Clinical Laboratory Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Shandong China

2. Shandong First Medical University and Shandong Academy of Medical Sciences Shandong China

3. Shandong Provincial Key Laboratory of Radiation Oncology Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Shandong China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13800

Reference31 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Lung cancer in People's Republic of China;Gao S;J Thorac Oncol,2020